Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay.
Lasse KjaerVibe SkovMorten T AndersenAnni AggerholmPhilippe ClairMichal GniotKaren SoebyLene UdbyMikkel H DorffHans HasselbalchNiels PallisgaardPublished in: European journal of haematology (2019)
Our findings suggest that the EAC qPCR assay may underestimate the e14a2 variant compared to the e13a2 variant.